跳至主要内容
临床试验/NCT06742255
NCT06742255尚未招募不适用

Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients

Assiut University0 个研究点目标入组 34 人开始时间: 2024年12月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
34
主要终点
Primary outcome: Average motor conduction latency in six muscle of the face

研究概览

简要总结

The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • facial nerve palsy patients

排除标准

  • light of a recent myocardial infarction.
  • anticoagulant use
  • lateral nerve palsy
  • cardiac conduction abnormalities
  • active infection, flu, cold
  • uncontrolled cough
  • Very high blood pressure or if you are on blood thinners.
  • allergic reaction to local anesthetics
  • Primary and secondary coagulopathy.

研究组 & 干预措施

stellate ganglion block group

干预措施: Stellate Ganglion Block (Drug)

结局指标

主要结局

Primary outcome: Average motor conduction latency in six muscle of the face

时间窗: 6 month

次要结局

  • Improved muscle tone(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Remonda zaki abdelnaeem zaki

Resident at anesthesia, intensive care and pain management, at Assiut University

Assiut University

相似试验